Legal Representation
Attorney
Glenn A. Gundersen
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 30, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 10, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 10, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 4, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 12, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 21, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 21, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Apr 21, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 1, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Apr 1, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Apr 1, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 1, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 27, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 27, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 4, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 4, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 4, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 29, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 17, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 15, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
molecules for use in the development of pharmaceutical preparations, namely, biological preparations for scientific research use
Class 005
pharmaceutical preparations for the treatment of cancers, immunological diseases, and inflammatory diseases; molecules for use in pharmaceutical preparations, namely, biological preparations for the treatment of cancers, immunological diseases, and inflammatory diseases
Class 042
scientific research and development; research and development in the field of pharmaceuticals; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; scientific investigations for medical purposes; development of molecules for use by others in developing and designing pharmaceutical preparations
Classification
International Classes
001
005
042